{"id":550885,"date":"2026-03-26T12:30:00","date_gmt":"2026-03-26T11:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=550885"},"modified":"2026-03-26T14:42:03","modified_gmt":"2026-03-26T13:42:03","slug":"il-23-and-il-17-as-a-target-selected-study-findings","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/il-23-and-il-17-as-a-target-selected-study-findings\/","title":{"rendered":"IL-23 and IL-17 as a target &#8211; selected study findings"},"content":{"rendered":"\n<p><strong>Although nail psoriasis remains a challenge, considerable progress has been made in both diagnostic and therapeutic terms. This is reflected, for example, in current analyses of the GUIDE and ZODIPSO studies as well as observational studies such as PSoSA. In addition, the use of high-resolution imaging techniques such as high-frequency ultrasound is being tested in order to optimize the assessment of the course of therapy.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fil-23-and-il-17-as-a-target-selected-study-findings%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Although nail psoriasis remains a challenge, considerable progress has been made in both diagnostic and therapeutic terms. This is reflected, for example, in current analyses of the GUIDE and ZODIPSO&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fil-23-and-il-17-as-a-target-selected-study-findings%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":550887,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Psoriasis in difficult localizations: Nail psoriasis  ","footnotes":"[{\"id\":\"8ff76a25-b2e5-4ab9-9883-c9b4d01eba6a\",\"content\":\"<em>Nail matrix: Leukonychia, \\\"pitting\\\", decay, red spots in the lunula; nail bed: onycholysis, splinter hemorrhages, subungual hyperkeratosis, oil droplets, discoloration.<\\\/em>\"},{\"id\":\"153468a1-b3ed-43c1-ad60-e7fc9be242f6\",\"content\":\"<em>SDD = short disease duration, LDD = long disease duration<\\\/em>\"},{\"id\":\"785d32be-01e4-4f7b-876b-823108d935bd\",\"content\":\"<em>f-PGA = fingernail Physician Global Assessment<\\\/em>\"},{\"id\":\"e16950d3-0d5b-465d-8315-3f4c32bdf76b\",\"content\":\"<em>DLQI = Dermatology Life Quality Index<\\\/em>\"}]"},"category":[11340,11508,11442,11480,11548,11503],"tags":[12391,17853,82357,18157,50991,34104,67747,12548,67731,12361,14032,26569,12536,26694,82352,67738,23439,89161],"powerkit_post_featured":[],"class_list":["post-550885","post","type-post","status-publish","format-standard","has-post-thumbnail","category-dermatology-and-venereology","category-education","category-pharmacology-and-toxicology","category-rheumatology","category-rx-en","category-studies","tag-biologics-en","tag-cosentyx-en","tag-guide-en","tag-guselkumab-en","tag-il-17-en","tag-il-23-en","tag-ilumetri-en","tag-ixekizumab-en","tag-localizations","tag-nail-psoriasis","tag-psoriasis-en-2","tag-risankizumab-en","tag-secukinumab-en","tag-skyrizi-en","tag-taltz-en","tag-tildrakizumab-en","tag-tremfya-en","tag-zodipso-psosa","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-20 09:44:09","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":550830,"slug":"il-23-et-il-17-comme-cibles-resultats-detudes-selectionnees","post_title":"IL-23 et IL-17 comme cibles - r\u00e9sultats d'\u00e9tudes s\u00e9lectionn\u00e9es","href":"https:\/\/medizinonline.com\/fr\/il-23-et-il-17-comme-cibles-resultats-detudes-selectionnees\/"},"it_IT":{"locale":"it_IT","id":550878,"slug":"il-23-e-il-17-come-bersaglio-risultati-di-studi-selezionati","post_title":"IL-23 e IL-17 come bersaglio - risultati di studi selezionati","href":"https:\/\/medizinonline.com\/it\/il-23-e-il-17-come-bersaglio-risultati-di-studi-selezionati\/"},"pt_PT":{"locale":"pt_PT","id":550888,"slug":"il-23-e-il-17-como-alvo-resultados-de-estudos-selecionados","post_title":"IL-23 e IL-17 como alvo - resultados de estudos selecionados","href":"https:\/\/medizinonline.com\/pt-pt\/il-23-e-il-17-como-alvo-resultados-de-estudos-selecionados\/"},"es_ES":{"locale":"es_ES","id":550831,"slug":"il-23-e-il-17-como-diana-resultados-de-estudios-seleccionados","post_title":"IL-23 e IL-17 como diana - resultados de estudios seleccionados","href":"https:\/\/medizinonline.com\/es\/il-23-e-il-17-como-diana-resultados-de-estudios-seleccionados\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/550885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=550885"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/550885\/revisions"}],"predecessor-version":[{"id":550889,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/550885\/revisions\/550889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/550887"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=550885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=550885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=550885"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=550885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}